Topics
Science

Issue 4: Nature Positive
An Antacid for the Ocean
Planetary Tech transforms mine waste into a carbon-removal tool. Peter Chargin, a Vice President at the company, speaks with Brunswick.
4 min read
Issue 4: Nature Positive
New Solutions for the Oceans
At a time when so many stories about the oceans are dispiriting, Brunswick spoke with five companies, large and small, that inspire a sense of hope.
3 min read
Issue 4: Nature Positive
The Business Path to Nature Positive
The New Nature Economy series, produced by the World Economic Forum, lays out the risks and opportunities for business. By Akanksha Khatri and Lucy Almond.
4 min read
Issue 4: Nature Positive
Health & Nature: A Critical Intersection
Not waiting for nature-positive standards, UK multinational GSK is taking action and a leadership role in the pharma and biotech sector. By Alastair Morton and Ellie Fallon.
8 min read
Issue 4: Nature Positive
Bird’s Eye View
Satellite-based tracking of CO2 and methane emissions represent the dawn of a new era for business transparency, says Antoine Rostand, CEO of tracking platform Kayrros.
9 min read
Unlocking the Science of Healthy Aging
Anti-aging research is accelerating, with profound implications for society. By Ben Hirschler.
7 min read
Issue 20: The WFH Issue
Testing Times
Brunswick’s Ben Hirschler describes taking part in a COVID-19 vaccine trial as part of the historic global effort to halt the disease.
9 min read
Issue 22: Acceleration
Critical Moment
On July 12, 2022, the first public images from the James Webb Space Telescope proved a revelation.
3 min read
Issue 22: Acceleration
Editor’s Letter: Acceleration
An introduction to The Acceleration Issue from the Editor in Chief.
3 min read
Issue 22: Acceleration
A Public Health Leader on COVID’s Lessons
Former US Surgeon General Dr. Jerome Adams talks with Brunswick’s Ninio Fetalvo.
11 min read
Issue 22: Acceleration
Dame Sally
Founded by England’s former Chief Medical Officer, The Trinity Challenge is engineering a collaboration between health, technology and data, for the benefit of mankind.
9 min read
Issue 22: Acceleration
A Vaccine Expert on Miracles, Misinformation and Missing Data
The Executive Director of Vaccines Europe sees cause for celebration—and concern.
11 min read